Axxcess Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,052
| Closed | -$424K | – | 942 |
|
|
2024
Q4 | $424K | Sell |
1,052
-1,798
| -63% | -$724K | 0.01% | 583 |
|
|
2024
Q3 | $1.33M | Buy |
2,850
+405
| +17% | +$188K | 0.03% | 334 |
|
|
2024
Q2 | $1.15M | Buy |
2,445
+217
| +10% | +$102K | 0.03% | 344 |
|
|
2024
Q1 | $931K | Buy |
2,228
+560
| +34% | +$234K | 0.03% | 385 |
|
|
2023
Q4 | $679K | Sell |
1,668
-329
| -16% | -$134K | 0.02% | 441 |
|
|
2023
Q3 | $694K | Buy |
1,997
+685
| +52% | +$238K | 0.02% | 386 |
|
|
2023
Q2 | $462K | Buy |
1,312
+60
| +5% | +$21.1K | 0.03% | 368 |
|
|
2023
Q1 | $394K | Sell |
1,252
-691
| -36% | -$218K | 0.03% | 419 |
|
|
2022
Q4 | $561K | Sell |
1,943
-903
| -32% | -$261K | 0.05% | 339 |
|
|
2022
Q3 | $824K | Sell |
2,846
-262
| -8% | -$75.9K | 0.08% | 217 |
|
|
2022
Q2 | $876K | Buy |
3,108
+22
| +0.7% | +$6.2K | 0.08% | 206 |
|
|
2022
Q1 | $805K | Buy |
3,086
+378
| +14% | +$98.6K | 0.06% | 257 |
|
|
2021
Q4 | $595K | Buy |
+2,708
| New | +$595K | 0.04% | 315 |
|